Evidence map›Paper›PMID 15809348›Full record

ReviewThe Journal of experimental medicine2005

Understanding how combinations of HLA and KIR genes influence disease.

Sumati Rajagopalan, Eric O Long

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 225 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Analysis of HLA Alleles in Different Cohorts of Patients Infected byInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Felty's syndrome.Frontiers in medicine · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sumati RajagopalanNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Eric O Long
National Institute of Allergy and Infectious Diseases · US

Funding

Regulation Of Natural Killer Cell ActivityZ01AI000842 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LONG, ERIC O · 1999 to 2008
$1.9M
6 · The paper itself

Abstract

Combinations of HLA and killer cell immunoglobulin-like receptor (KIR) genes have been associated with diseases as diverse as autoimmunity, viral infections, reproductive failure, and now cancer. Much as early observations of disease associations with HLA polymorphism preceded a detailed knowledge of HLA recognition by T cell receptors, the recently reported disease associations with HLA-KIR gene combinations beg for a better understanding of the underlying mechanisms.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticGenes, MHC Class IGenotypeHumansModels, GeneticPeptidesReceptors, ImmunologicReceptors, KIRPeptidesReceptors, ImmunologicReceptors, KIR

Identifiers

PMID15809348
PMCPMC2213130
OpenAlexW2119687069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.